Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single-Arm Study of Compound Granules of Hedyotis Diffusa for Chronic Atrophic Gastritis
NCT07391800Not yet recruiting
- Sponsor
- Shanghai General Hospital
- Start
- Jan 2026
- Primary completion
- Jul 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of hedyotis diffusa in chronic atrophic gastritis (CAG), sponsored by Shanghai General Hospital. Primary endpoint: Pathologic Diagnosis at 1 year. Planned start Jan 2026; status: not yet recruiting.
02
Drugs
hedyotis diffusa
03
Conditions
chronic atrophic gastritis (CAG)
Beyond the preview
Go deeper on NCT07391800.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07391800.